A share price of Pfizer Inc. [PFE] is currently trading at $29.60, up 3.64%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PFE shares have gain 2.71% over the last week, with a monthly amount glided 12.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pfizer Inc. [NYSE: PFE] stock has seen the most recent analyst activity on March 22, 2024, when Argus downgraded its rating to a Hold. Previously, Guggenheim started tracking the stock with Buy rating on February 23, 2024, and set its price target to $36. On January 04, 2024, downgrade downgraded it’s rating to Market Perform but maintained its price target of $32 on the stock. Jefferies upgraded its rating to a Buy and raised its price target to $39 on October 16, 2023. JP Morgan reiterated a Neutral rating for this stock on July 17, 2023, and downed its price target to $41. In a note dated July 14, 2023, HSBC Securities initiated an Buy rating and provided a target price of $50 on this stock.
Pfizer Inc. experienced fluctuations in its stock price throughout the past year between $25.20 and $40.37. Currently, Wall Street analysts expect the stock to reach $55.44 within the next 12 months. Pfizer Inc. [NYSE: PFE] shares were valued at $29.60 at the most recent close of the market. An investor can expect a potential return of 87.3% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Trailing Twelve Months sales for Pfizer Inc. [NYSE:PFE] were 55.09B which represents -18.61% decline. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.80 points at the first support level, and at 28.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.01, and for the 2nd resistance point, it is at 30.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pfizer Inc. [NYSE:PFE] is 1.05. As well, the Quick Ratio is 0.78, while the Cash Ratio is 0.02. Considering the valuation of this stock, the price to sales ratio is 3.04, the price to book ratio is 1.82.
Transactions by insiders
Recent insider trading involved Gottlieb Scott, Director, that happened on Dec 15 ’23 when 3000.0 shares were purchased.
